We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
-5.17%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
-$821M
(-12%)
Cap. Flow
-$392M
Cap. Flow
% of AUM
-6.36%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
911
New
217
Increased
113
Reduced
100
Closed
202
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$100M |
| 2 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$97M |
| 3 |
Lam Research
LRCX
|
+$85.4M |
| 4 |
Boston Scientific
BSX
|
+$79.4M |
| 5 |
Merck
MRK
|
+$67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$145M |
| 2 |
ASML
ASML
|
+$119M |
| 3 |
Qorvo
QRVO
|
+$89M |
| 4 |
Microsoft
MSFT
|
+$82.9M |
| 5 |
Intuitive Surgical
ISRG
|
+$75.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.56% |
| 2 | Technology | 29.01% |
| 3 | Industrials | 8.79% |
| 4 | Communication Services | 5.99% |
| 5 | Financials | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGEN
1
DELISTED
Seagen Inc. Common Stock
SGEN
| $203M | 3.29% |
1,407,693
+739,689
| +111% | +$100M |
|
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $143M | 2.32% |
316,200
-18,700
| -6% | -$8.33M |
|
3
Cooper Companies
COO
$13.7B
| $103M | 1.68% |
990,036
+145,468
| +17% | +$14.6M |
|
|
ZNGA
4
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $102M | 1.66% |
+11,039,458
| New | +$97M |
|
|
5
Boston Scientific
BSX
$65.8B
| $81.1M | 1.32% |
+1,831,659
| New | +$79.4M |
|
|
6
Lam Research
LRCX
$382B
| $78.9M | 1.28% |
+1,467,560
| New | +$85.4M |
|
7
KLA
KLAC
$275B
| $76.8M | 1.25% |
2,096,640
+1,643,710
| +363% | +$61.5M |
|
8
Regeneron Pharmaceuticals
REGN
$68.8B
| $73.7M | 1.2% |
105,494
+15,248
| +17% | +$9.65M |
|
|
9
Merck
MRK
$324B
| $71.3M | 1.16% |
869,391
+849,367
| +4,242% | +$67M |
|
10
Danaher
DHR
$135B
| $69.9M | 1.13% |
268,622
-55,384
| -17% | -$13.9M |
|
11
Alphabet (Google) Class A
GOOGL
$3.91T
| $67.4M | 1.09% |
484,880
-11,800
| -2% | -$1.6M |
|
12
Stanley Black & Decker
SWK
$14.2B
| $67.3M | 1.09% |
481,778
+337,847
| +235% | +$55.8M |
|
13
Procter & Gamble
PG
$343B
| $64.9M | 1.05% |
424,749
+206,062
| +94% | +$32.2M |
|
14
Arrow Electronics
ARW
$10.9B
| $64.2M | 1.04% |
541,114
+54,671
| +11% | +$6.85M |
|
|
SPLK
15
DELISTED
Splunk Inc
SPLK
| $63.6M | 1.03% |
+428,155
| New | +$52.4M |
|
16
TE Connectivity
TEL
$58.8B
| $60.5M | 0.98% |
461,682
+459,602
| +22,096% | +$65.7M |
|
17
Revolution Medicines
RVMD
$40.2B
| $59.5M | 0.97% |
2,331,395
-598,643
| -20% | -$13M |
|
18
Dell
DELL
$283B
| $57.9M | 0.94% |
1,154,036
+345,488
| +43% | +$19.3M |
|
19
Cigna
CI
$76.6B
| $54.2M | 0.88% |
+226,135
| New | +$52.9M |
|
20
AT&T
T
$165B
| $52.1M | 0.85% |
2,918,571
+174,128
| +6% | +$3.22M |
|
21
Johnson & Johnson
JNJ
$634B
| $50.7M | 0.82% |
285,960
-233,187
| -45% | -$39.7M |
|
22
Lyft
LYFT
$5.39B
| $47.5M | 0.77% |
+1,237,102
| New | +$48.4M |
|
23
L3Harris
LHX
$55.9B
| $45.1M | 0.73% |
181,426
+65,938
| +57% | +$15.4M |
|
24
Booking.com
BKNG
$138B
| $44M | 0.71% |
+468,250
| New | +$43.8M |
|
|
CERN
25
DELISTED
Cerner Corp
CERN
| $43.5M | 0.71% |
465,299
+236,575
| +103% | +$21.9M |
|
Similar funds
KAS
PAM
TCIIS
Woodline Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Woodline Partners held 911 positions worth $6.16B, down 12% from $6.98B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Woodline Partners withdrew a net $392M in Q1 2022, closing 202 positions and reducing 100 holdings. Its most notable exit was AbbVie, an estimated $145M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.
Against the trend, Woodline Partners opened a new position in ZYNGA INC. CL A COMMON worth $102M.
- Woodline Partners's largest Q1 2022 buy was ZYNGA INC. CL A COMMON: 11,039,458 shares worth $102M.
- Woodline Partners added most to Seagen Inc. Common Stock in Q1 2022, an estimated $100M increase.
- Woodline Partners's biggest Q1 2022 reduction was Qorvo, cutting an estimated $89M.
- Woodline Partners fully exited AbbVie in Q1 2022, selling an estimated $145M.
- Woodline Partners's ten largest holdings make up 16% of its $6.16B portfolio in Q1 2022.
- Woodline Partners opened 217 new positions and closed 202 in Q1 2022.
- Woodline Partners's portfolio value fell 12% quarter-over-quarter to $6.16B.
Based on Woodline Partners's 13F filing for Q1 2022, filed 16 May 2022.